Estraderm and fibrocystic breast disease Patient Reports February 10, 2012

Estraderm Side Effects Report #5518965-3
Estraderm side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 07, 2007. Female patient, 67 years of age, weighting 112.0 lb, was diagnosed with menopause  and was treated with Estraderm. After drug was administered, patient experienced the following side effects: adenoidectomy, arthritis , breast cancer , breast discharge, breast prosthesis removal, colon adenoma, emotional distress, fibrocystic breast disease, hot flush. Estraderm dosage: 0.05 MG, TWICE WEEKLY. During the same period patient was treated with XANAX, ALPRAZOLAM, INDOCIN, PROVERA, CYCRIN, ESTROGEN NOS, MEDROXYPROGESTERONE. Patient recovered.

Estraderm Side Effects Report #5528625-0
Estraderm side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 09, 2007. Female patient, 67 years of age, weighting 112.0 lb, was diagnosed with menopause  and was treated with Estraderm. After drug was administered, patient experienced the following side effects: arthritis , breast cancer , breast discharge, emotional distress, fibrocystic breast disease, hot flush, malignant breast lump removal, mass, menopausal symptoms. Estraderm dosage: 0.05 MG, TWICE WEEKLY, TRANSDERMAL. During the same period patient was treated with PROVERA, CYCRIN, ESTROGENS SOL, MEDROXYPROGESTERONE, CLIMARA, PREMARIN, ESTRACE. Patient recovered.

Estraderm Side Effects Report #5528628-6
Estraderm side effect was reported by a Physician from UNITED STATES on Apr 23, 2007. Female patient, 51 years of age, weighting 160.1 lb, was diagnosed with menopause  and was treated with Estraderm. After drug was administered, patient experienced the following side effects: anxiety , breast cancer , breast mass, breast tenderness, chest pain , depression , electrocardiogram abnormal, fibrocystic breast disease, hypertension. Estraderm dosage: 0.05 MG, TRANSDERMAL. During the same period patient was treated with PROVERA, PREMARIN, ESTRACE, PROGESTERONE, RANITIDINE. Patient was hospitalized. Patient recovered.

Estraderm Side Effects Report #5528626-2
Estraderm side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 16, 2007. Female patient, weighting 149.9 lb, was diagnosed with menopause  and was treated with Estraderm. After drug was administered, patient experienced the following side effects: breast cancer , breast hyperplasia, breast mass, depression , fibrocystic breast disease, leiomyoma, lymphadenectomy, malignant breast lump removal, ovarian cyst . Estraderm dosage: 0.05 MG, BIW, TRANSDERMAL. During the same period patient was treated with PROVERA, PREMARIN. Patient recovered.


Estraderm Side Effects Report #5829012-8
Estraderm side effect was reported by a Consumer or non-health professional from UNITED STATES on July 24, 2008. Female patient, weighting 138.0 lb, was diagnosed with menopause  and was treated with Estraderm. After drug was administered, patient experienced the following side effects: arthralgia, biopsy, biopsy breast abnormal, breast cancer , breast necrosis, dyspnoea, fibrocystic breast disease, mammogram abnormal, musculoskeletal pain. Estraderm dosage: 0.05 MG/DAY, UNK. During the same period patient was treated with VIVELLE, COMBIPATCH, ESTRATEST, PROVERA, PREMARIN, PREMPRO. Patient recovered.

Estraderm Side Effects Report #5527972-6
Estraderm side effect was reported by a Physician from UNITED STATES on Apr 16, 2007. Female patient, 73 years of age, weighting 129.0 lb, was diagnosed with menopausal symptoms and was treated with Estraderm. After drug was administered, patient experienced the following side effects: breast cancer in situ, breast microcalcification, breast necrosis, breast reconstruction , fibrocystic breast disease, mastectomy , oestrogen receptor assay positive, osteopenia, progesterone receptor assay positive. Estraderm dosage: 0.5 MG, BIW, TRANSDERMAL. During the same period patient was treated with PREMARIN, PROVERA, MEDROXYPROGESTERONE. Patient recovered.

Estraderm Side Effects Report #5528223-9
Estraderm side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 18, 2006. Female patient was diagnosed with menopausal symptoms and was treated with Estraderm. After drug was administered, patient experienced the following side effects: arthritis , breast cancer , breast mass, breast microcalcification, cough, cystitis interstitial, dyspepsia, fibrocystic breast disease, hot flush. Estraderm dosage: unknown. During the same period patient was treated with PREMARIN, ESTRATEST, CLIMARA. Patient was hospitalized. Patient recovered.

Estraderm Side Effects Report #5528971-0
Estraderm side effect was reported by a Consumer or non-health professional from UNITED STATES on June 01, 2007. Female patient, 66 years of age, weighting 129.0 lb, was treated with Estraderm. After drug was administered, patient experienced the following side effects: blood cholesterol increased, breast cancer , breast cyst, breast microcalcification, diagnostic procedure, fibrocystic breast disease, hypertension, malignant breast lump removal. Estraderm dosage: 0.5 MG, TRANSDERMAL. During the same period patient was treated with PROVERA, PREMPRO, PREMARIN, CHLORTHALIDONE. Patient recovered.

Estraderm Side Effects Report #5528970-9
Estraderm side effect was reported by a Physician from UNITED STATES on June 01, 2007. Female patient, 60 years of age, weighting 185.0 lb, was diagnosed with menopause  and was treated with Estraderm. After drug was administered, patient experienced the following side effects: amyloidosis, breast cancer in situ, breast hyperplasia, breast microcalcification, fibrocystic breast disease, hypertension, mastectomy , oedema peripheral, osteoarthritis . Estraderm dosage: unknown. During the same period patient was treated with PREMPRO, PROVERA, CYCRIN, MEDROXYPROGESTERONE ACETATE, ELAVIL, AMITRIPTYLINE, ASACOL, HYOSCYAMINE. Patient recovered.


Estraderm Side Effects Report #5345381-X
Estraderm side effect was reported by a Physician from UNITED STATES on May 25, 2007. Female patient, 56 years of age, weighting 140.0 lb, was diagnosed with menopause  and was treated with Estraderm. After drug was administered, patient experienced the following side effects: breast cancer metastatic, breast hyperplasia, breast microcalcification, depression , fibrocystic breast disease, hepatic steatosis, hysteroscopy, liver disorder, liver function test abnormal. Estraderm dosage: 0.05MG. During the same period patient was treated with PREMPHASE, CYCRIN, ESTRATEST, PREMARIN, PROVERA, ESTRACE, PREMPRO. Patient recovered.